πŸ‡ΊπŸ‡Έ FDA
Patent

US 10273218

BCL-3 inhibitors

granted A61PA61P35/00A61P35/02

Quick answer

US patent 10273218 (BCL-3 inhibitors) held by University College Cardiff Consultants Limited expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
University College Cardiff Consultants Limited
Grant date
Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P35/00, A61P35/02